21 November 2024

Howe Street Reporter Title

Category: Psychedelics

  • Market positivity leads to psychedelic space love, is the sector slump over? – Today’s Idea

    Market positivity leads to psychedelic space love, is the sector slump over? – Today’s Idea

    We’re not out of the woods yet, but the major indices are turning green again and psychedelics, recently a relative investment pariah, are getting some love from investors. The appreciation isn’t absolute, but many companies in the space are experiencing a much-needed bump. I want to focus on four psychedelics companies, each pursuing a different…

  • MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

    MYND Life Sciences (MYND.C) provides unorthodox route to better mental health

    We’re living in interesting times and I mean that in the Chinese curse kind of way. We can’t seem to stop to catch our breath when it comes to this pandemic, and the news sources we trust to keep us informed can’t seem to get the story straight. The result is more isolation, frustration, and…

  • If I had a billion dollars: psychedelics sector edition

    If I had a billion dollars: psychedelics sector edition

    The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble, that speculative fantasy no longer bears the same relevance and needs to be ramped up insanely to have any impact. As a thought experiment, let’s pretend…

  • Filament Health (FH.NEO): fighting the good fight against anxiety and depression

    Filament Health (FH.NEO): fighting the good fight against anxiety and depression

    You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…

  • Small cap psychedelics stocks – Today’s Idea

    Small cap psychedelics stocks – Today’s Idea

    The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in the sector that have differentiated themselves, let’s examine them and their potential value: Mind Cure Health (MCUR.C) is based in Vancouver, Canada and according to its website is a company…

  • Mind Cure Health (MCUR.C): a hidden psychedelics gem – Today’s Idea

    Mind Cure Health (MCUR.C): a hidden psychedelics gem – Today’s Idea

    The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments aren’t providing the sustainable answers we need, so companies like Mind Cure Health (MCUR.C) have integrated ancient therapeutics with modern modalities and technologies to effectively heal…

  • Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…

  • To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    To Invest or Not: Pure Extracts Technologies Corp. (PULL.C)

    In this episode, we take a look at a cannabis, hemp and psychedelics extraction company based in British Columbia that goes by the name Pure Extracts Technologies Corp. (PULL.C). The company offers various derivative cannabis products such as Pure Mushrooms, which are daily supplements aimed at boosting the immune system and overall health and wellness;…

  • First Glance with Jody Vance: Pure Extracts (PULL.C)

    First Glance with Jody Vance: Pure Extracts (PULL.C)

    In episode 69, Jody chats with Pure Extracts (PULL.C) CEO Ben Nikolaevsky to get an insight into the companies latest updates and plans. Pure Extracts operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts.

  • MINDCURE (MCUR.C) – Five Easy Questions with Maddy

    MINDCURE (MCUR.C) – Five Easy Questions with Maddy

    Today Maddy speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden. Kelsey breaks down the burgeoning therapeutic world of psychedelics and outlines Mindcure’s uniquely comprehensive approach of utilizing psychedelics with digital follow ups to treat such conditions as depression and women’s loss of sexual desire. Tune in!